Objectives Preterm premature rupture of membranes (PPROM) is a leading complication following fetoscopic laser coagulation (FLC) for twin-twin transfusion syndrome (TTTS). Our primary objective was to describe the impact of improvements in surgical technique on survival and rate of PPROM over time. The secondary objective was to assess potential risk factors for PPROM.
Introduction
Although fetoscopic surgery has become the first-line treatment for twin-twin transfusion syndrome (TTTS), 1 it is associated with significant morbidity and preterm birth, which are largely related to preterm premature rupture of the membranes (PPROM). Reported rates of PPROM following fetoscopic surgery for TTTS vary widely, ranging from 0 to 50% in a recent review of the literature. 2 This wide range is at least partly related to the variable definitions of PPROM adopted in the context of fetoscopic surgery for TTTS, 2 encompassing PROM within 2 or 3 weeks following surgery, PROM at <37 weeks, PROM at <36 weeks or PROM once viability has been reached. PPROM at <34 weeks occurs in 28-40% of the cases. 3, 4 Despite the obvious relation of PPROM and preterm birth, 3 paediatric outcomes following PPROM have been poorly studied, especially postnatal mortality and morbidity. Although possible risk factors include access port diameter 2, 3, 5 and chorionic membrane separation at entry site, 6, 7 the impact of refining surgical technique has not been studied, except perhaps for recent reports suggesting an increased risk of PPROM using the 'Solomon' technique. 8 In this study, we take advantage of a large cohort of >1000 cases of TTTS operated by fetoscopic laser surgery in a single centre over a 16-year period to describe the impact of improving surgical technique on the outcome and how this affects the incidence of PPROM. Using survival analyses, we found a continuous increase in PPROM rate together with an overall increase in survival over time. Despite the burden of preterm birth with PPROM, we found rather reassuring perinatal and neonatal prognoses when PPROM occurred after 20 weeks. However, early PPROM at <20 weeks carries a high rate of miscarriage and indicates a risk of very early preterm birth.
Methods

Patients
We retrospectively reviewed all cases of monochorionic twin pregnancies referred to our unit for twin-twin transfusion syndrome since 2000. Gestational age was defined by crown-rump length measurement of the larger twin at 11-14 weeks in spontaneous pregnancies and by date of conception in IVF pregnancies. Chorionicity was assessed by ultrasound before 15 weeks in all cases. Twin-to-twin transfusion syndrome was defined by a deepest vertical pool >10 cm at >20 +0 weeks' and >8 cm at <20 +0 weeks gestation in one twin together with a DVP <2 cm in the co-twin, as previously. 1 All cases were treated surgically except for a subset of Quintero-stage 1 diseases, which were allocated to expectant management following randomisation over the last 4 years (TTTS1 trial, NCT01220011).
Under French law, this study was exempt from institutional review board review because its methodology (observational study during routine standard of care) was not experimental and did not affect the patients' routine prenatal management.
Procedures
Preoperative assessment included maternal history, fetal biometry, umbilical artery, ductus venosus and middle cerebral artery velocimetry, and cervical length. Surgery was planned within 48 hours following referral. In all cases, surgery was performed by percutaneous fetoscopic laser coagulation of placental vessels, using a 1.3-or 2-mm Storz flexible fetoscope (Storz GmbH) and an Nd-YAG or Diode laser generator (Dornier MedTech GmbH). The fetoscope is inserted in the polyhydramniotic cavity under local or epidural analgesia using an 8-or 10-Fr trocar, under ultrasound guidance (Voluson 730 or Voluson E8, General Electrics). Amnioinfusion of warm saline is used whenever it was deemed necessary. Surgeries ended with an amnioreduction to achieve a DVP of <6 cm and keeping the amount drained at <4 liters.
Although it could not be supported by recorded data, increasing awareness of the impact of selective coagulations on outcome progressively shifted our technique from nonselective surgeries in earlier cases to completely selective surgeries along the vascular equator in later cases, after 2008. 9 Furthermore, following the communications of the results of the 'Solomon' trial 10 in 2013, we further refined our surgical technique by extending selective coagulations with continuous chorionic coagulation along the vascular equator. In cases with short cervical length (<15 mm) prior to surgery, the decision to place a cerclage was left to the attending surgeon.
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Following surgery, all patients were followed up weekly either in our unit or in the referring centre. An MRI is systematically offered at 28-32 weeks. Although this may not be the case in all referring units, we advise delivery at no later than 35 +0 weeks' gestation, preferentially by caesarean section. In the case of PPROM, antibiotics were systematically given for 48 hours (amoxicillin or clindamycin) and steroids for lung maturation were given at >24 weeks (betamethasone). A second course of steroids could be given if delivery did not occur within the following 2 weeks. Perinatal neuroprotection by magnesium sulphate was not used over the study period. We would typically plan delivery at no later than 33 +0 weeks. However, some patients do not deliver in our centre and might have been delivered at a later gestational age in accordance with local protocol.
Outcomes and data
Preterm premature rupture of membranes was defined by documented pooling associated with oligohydramnios in either twin, confirmed by a nitrazine test. Miscarriage was defined by spontaneous delivery at <24 weeks. Neonatal survival and morbidity was defined at 28 days or at hospital discharge. Severe neonatal brain damage was defined as either intraventricular haemorrhage grade 3 or 4 or periventricular haemorrhage. We defined a composite adverse neonatal outcome as neonatal death (<28 days) or severe neurological damage comprising intraventricular haemorrhage grade 3 or 4 or periventricular leucomalacia. Regarding the outcome, we stratified the analysis per gestational age at PPROM, using two groups: very early PPROM at <20 weeks and PPROM at ≥20 weeks. Gestational age is reported in exact weeks of gestation. All data regarding maternal demographics and prenatal follow up are recorded in a dedicated database (Astraia GmbH). Data regarding postnatal follow up are recorded in a separate dedicated MySQL database.
Statistical analysis
Preterm premature rupture of membranes is the primary event of interest. However, following surgery, several events including delivery, miscarriage, dual intrauterine fetal death (IUFD) and, possibly, termination of pregnancy compete with PPROM in the sense that their occurrence precludes the occurrence of the primary event of interest. Therefore, the analysis of the incidence of this event was studied using time-to-event (survival) methods, which allowed us to describe the time-wise risk of PPROM and competing outcomes following surgery by cumulative incidences. 12 As PPROM was the outcome of interest, competing outcomes were grouped in a single outcome defined as delivery at any gestational age and for any reason (i.e. miscarriage, dual IUFD, TOP, as well as dual survival). Analyses were performed using surgery or date of pregnancy as time of origin, depending on the situation. Differences between cumulative incidences were determined by Gray's test, whenever relevant. Risk factors for PPROM were analysed by cause-specific hazard ratios (HR), computed using standard Cox models and censoring all competing risks. 13 The changes in outcome over time in the 16-year span of this study were described by monitoring the rates of PPROM and survival (total number of events/sample size) within 2-year epochs.
All analyses were performed with R (R Foundation for Statistical Computing, https://www.R-project.org) using packages 'survival' and 'cmprsk'.
No funding was obtained for this study.
Results
Over at <24, <26, <28, <30, <32 and <34 weeks were 4, 8, 12, 19, 25 and 28%, respectively. The rates of PPROM at <32 weeks across the study period is presented in Figure 2 , along with the rates of dual loss at 28 days, dual survival at 28 days and delivery at <32 weeks. The increasing rate of PPROM at <32 weeks, from 15% in 2000-2002 to 40% in 2015-2016, is concomitant with a moderate increase in deliveries at <32 weeks. However, it mirrors a two-fold drop in dual losses at 28 days, together with a steep rise in dual survivors at 28 days, from 42% in 2000-2002, reaching 66% in 2015-2016. The rate of pregnancies with at least one twin alive rose similarly, from 80 to 91% between the beginning and the end of the study period (data not shown). The increase in the rate of PPROM is also seen on the cumulative incidences stratified across the study period (Figure S1 ; P < 0.001), showing that since 2000, PPROM has occurred more frequently and earlier with time: the rate of PPROM per postoperative week rose from 1% in 2000 to 4% in 2016. The rate of Quintero stages ≥3 did not change over the study period, nor did the rate of anterior placenta and median gestational age at surgery (median gestational 20-21 weeks throughout, data not shown). However, there was a significant and linear increase in the rates of surgeries performed at <17 weeks from 3.9 to 10% between 2000 and 2009, stabilising thereafter until 2016 (data not shown).
The trends in survival at 28 days differed significantly between pregnancies with PPROM at <32 weeks and those without PPROM at <32 weeks. Figure 3 presents the number of surviving twins per pregnancy across the study period in cases with versus without PPROM at <32 weeks. In cases without PPROM at <32 weeks (lower panel, in blue), dual survival steadily increased from 49 to 67%, whereas dual loss dropped from 22 to 6%. In cases with PPROM at <32 weeks (upper panel, in red), although the rate of dual loss remained relatively stable, there was a significant shift between twin survivors and singleton survivors: the rates of singletons and dual survivors were 78 and 11%, respectively, in 2000-2002 compared with 26 and 60% in 2015-2016.
We analysed several risk factors for PPROM: early gestational at surgery (<17 +0 weeks), placental location, Quintero stages and cervical length at surgery. Given the observed improvement in dual survival over time, we also considered the number of fetuses surviving at birth as a potential risk factor, hypothesising that a twin intrauterine load would be at higher risk than a singleton load. Gestational age at surgery was analysed using date of pregnancy as the time of origin. All other variables were analysed using date of surgery. The relation with the number of twins alive at 28 days was analysed in the subset of patients with at least one twin alive. The resulting hazards ratios are presented in Table 1 .
The effect of gestational age at surgery on PPROM is complex. Figure 4 shows the cumulative incidence of PPROM stratified by gestational age at surgery using date of pregnancy Rates of PPROM at <32 weeks, dual loss at 28 days, dual survival at 28 days and delivery at <32 weeks across the study period.
(left) and surgery (right) as time of origin. In Table 1 , we have shown that patients operated at <17 weeks, rupture significantly more and at an earlier gestational age. However, in Figure 4 , the behaviour of the earliest cases (<17 weeks) shows two trends: a steep slope within the first 2 weeks following surgery, followed by a 6-week plateau, preceding a second increase in the risk of PPROM. In other words, compared with later surgeries, TTTS at <17 weeks carries an additional risk of PPROM of 10% within 1 week following surgery. Within the cases operated at ≥17 weeks, the relation between gestational age at surgery and PPROM persists with a greater risk of PPROM at earlier gestational ages, but without the first slope seen in <17-week cases. However, following surgery, PPROM occurs later, i.e. with a longer interval following surgery, in the earlier cases, as shown in the right-hand panel of Figure 4 , using surgery as time of origin. Indeed, in the left panel, the risk of PPROM in the earliest cases catches up with the later cases between 30 and 32 weeks, except for those operated at <17 weeks. Chorioamnionitis occurred in 54 cases (5.2%); 72% of these followed PPROM, whereas 28% occurred with intact membranes.
The mean time interval between PPROM and delivery is strongly correlated to the gestational age at PPROM: 7 weeks, 4 weeks, 2 weeks, 1 week and 2 days for PPROM occurring at <20 +0 , 20 +1 to 24 +0 , 24 +1 to 28 +0 , 28 +1 to 32 +0 and >32 +0 weeks, respectively. Neonatal mortality and neurological morbidity of liveborn neonates (n = 1499) is presented in Table 2 , stratified across gestational age at delivery and according to the occurrence of PPROM during pregnancy on either sac. Apart from a significantly higher survival at <26 weeks in cases with PPROM, we did not find differences in terms of survival, severe brain damage (HIV grade 3/4 or periventricular leucomalacia) or a composite outcome of death or severe brain damage across gestational age at delivery. The effect of PPROM on perinatal and neonatal outcome (n = 1017 pregnancies) is presented in Table 3 , breaking down gestational age at PPROM into two groups: <20 weeks (n = 21) and ≥20 weeks (n = 272). Following very early PPROM (<20 weeks), miscarriages occurred in 52% of cases. However, in the 10 remaining cases, gestational age at delivery was ≥32 weeks in most cases, and the rate of adverse neonatal outcome 10%, no different from that of pregnancies that did not rupture or ruptured later (≥20 weeks). Interestingly, in those 10 pregnancies, no newborn died from pulmonary hypoplasia. Except for a significantly higher rate of deliveries between 28 and 32 weeks, the overall survival was not different between pregnancies with PPROM at ≥20 weeks and those that did not rupture. Nonetheless, neonates delivered from PPROM pregnancies were overall at higher risk of neonatal mortality or neurological impairment essentially because of the associated increase in preterm birth, although this difference did not reach significance (Table 2 ; P = 0.16).
Discussion
Main finding
In this large series of fetoscopic laser coagulation of intertwin anastomoses in TTTS, both survival and rates of PPROM have risen significantly over 16 years. Therefore, over the course of the study period, postoperative complications have shifted from intrauterine fetal demise and miscarriage to complications that affect ongoing pregnancies, mainly PPROM and preterm birth.
Strengths and limitations
The strengths of this study are the large sample size, complete pre-and postnatal follow up with a low number of lost to follow-up as well as appropriate statistical methods to estimate the incidence of postoperative complications. Nonetheless, given its retrospective design, this study has limitations: we did not record possibly important surgical variables such as a complete visualisation of the equator, duration of surgery, total amount of energy delivered or postoperative chorionic membrane separation.
Interpretation
Several factors have contributed to this shift towards nonlethal postoperative complications. 1 Case selection prior to surgery. Although Quintero stages and placental location did not change over the study period, the number of early surgeries did increase. This is likely to be related to earlier and better identification of TTTS following national guidelines for the management of TTTS, published in 2009. 15 This may explain, at least partly, the increase in PPROM, as we have shown that surgery at <17 weeks was a significant risk factor, in contrast to previous reports in smaller series. 16, 17 However, this trend of early referrals does not improve perinatal survival and therefore does not explain the increase in survival we observed. 2 Changes in management of PPROM are unlikely, as no substantial change in management protocol was introduced during the study period. Furthermore, although dual survival did increase with time in patients with PPROM, this only represented a reduction in the rates for single survivors, not dual losses (Figure 3, upper  panel) . Therefore, obstetric management following PPROM is not responsible for the increase in survival, which would have reduced the rate of dual loss following PPROM. However, improvements in postnatal care over the study period are likely to have had an effect on the improvement of survival, 18 despite the increase in PPROM.
3 Surgical technique is probably the most prominent factor.
Substantial changes were introduced throughout the study period: first, a gradual improvement in the selectivity of the procedure between 2000 and 2008 9, 19 and secondly, the introduction of the 'Solomon' technique. 10 Although this technique was shown significantly to reduce the incidence of twin anaemia-polycythemia sequence and recurrence of the disease, 20 perinatal survival was similar with and without coagulation of the entire equator in the initial report. 10 However, recent reports and a review of the literature suggests the 'Solomon' technique could improve perinatal survival as well. 21, 22 Nonetheless, there are concerns that the amount of coagulation required to complete the procedure could lead to significant placental damage, increasing the occurrence of PPROM and preterm birth. 8 In our cohort, surgeries progressively shifted towards the use of a complete 'Solomon' technique between 2012 and 2013, which coincides with a steep rise in perinatal survival (Figure 2 ), therefore suggesting a causal relationship. Gradual improvement in skill is also the only reasonable explanation for the survival patterns we observe over time in cases with PPROM ( Figure 3 , upper panel): it is likely that improving our ability to anticipate and visualise the vascular equator while avoiding breaking through the placenta is especially critical for survival in early cases at high risk of PPROM. The main risk factor for PPROM was indeed early surgery at <17 weeks, which carries a hazard ratio of 1.78 (1.24-2.56) compared with surgeries performed later. Following surgery, this specific population is at higher risk mostly because of a high rate of very early immediate postoperative PPROM (within 1 week postoperatively) occurring in >10% in this subpopulation (Figure 4 ). This excess of immediate postoperative PPROM was not seen in later surgeries where the risks was rather stable, as shown by the linear cumulative incidence of PPROM, suggesting a specific pathophysiology, possibly related to the development of the uterus, placenta and membranes that underlies iatrogenic postoperative PPROM in early surgery. Immediate postoperative PPROM is a severe complication of early fetoscopic surgery, and although TTTS may be cured, this complication carries an exceedingly high rate of miscarriage of almost 60% (Table 2 ). Nonetheless, when these patients did not miscarry, the prognosis, in terms of gestational age at delivery and postnatal survival, was comparable to patients with later PPROM or even to those without PPROM. Despite an obvious relation between PPROM at >20 weeks and preterm birth, the overall survival was similar in those with PPROM and those without PPROM. Although this did not reach significance, the higher rate of severe postnatal event (i.e. postnatal death or severe brain damage) following PPROM at >20 weeks is noticeable (Table 3 ) and should raise concerns regarding an increase in PTB-related morbidity. Nonetheless, with survival rates that closely match those reported by others in newborns, 18, 23 PPROM did not affect neonatal morbidity or mortality when stratifying on gestational age at birth (Table 2 ) and therefore does not appear to be an independent risk factor for neonatal outcome.
Conclusions
The overall increase in survival we observed over time was associated with a rather reassuring perinatal and neonatal prognosis following PPROM. However, the significant increase in the incidence of this iatrogenic complication and the associated burden of preterm birth and related morbidities and mortality warrants the development of preventive and therapeutic strategies. Several research avenues could be explored: (1) preventively plugging the entry hole at the end of surgery with a biocompatible construct such as collagen 4, 24 or a gelatin sponge, 25 although such strategies have not shown consistent improvement in published reports and deserve further investigation; (2) reducing the diameter of the entry port; (3) treating PPROM by injecting a sealant. 26 These candidate strategies should be evaluated in randomised trials, which, we believe, is the next step in refining fetoscopic surgery for TTTS.
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